These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26306727)

  • 21. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
    Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
    Xia X; Luo J; Bai J; Yu R
    Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
    Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
    Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
    Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
    Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
    Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AjUDE-Brasil I Project.
    Zocratto KB; Caiaffa WT; Proietti FA; Carneiro-Proietti AB; Mingoti SA; Ribeiro GJ;
    Cad Saude Publica; 2006 Apr; 22(4):839-48. PubMed ID: 16612437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of HIV and HCV infections among injection drug users in northeast India.
    Mahanta J; Borkakoty B; Das HK; Chelleng PK
    AIDS Care; 2009 Nov; 21(11):1420-4. PubMed ID: 20024719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
    BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.
    Palmer C; Hampartzoumian T; Lloyd A; Zekry A
    Hepatology; 2008 Aug; 48(2):374-84. PubMed ID: 18666256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal.
    Kakchapati S; Maharjan M; Rawal BB; Dixit SM
    Arch Public Health; 2017; 75():39. PubMed ID: 28878895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.